Soft Tissue Repair Market

Soft Tissue Repair Market by Product (Mesh/Tissue patch, Allograft, Xenograft, Suture Anchor, Interference Screws, Laparoscopic Instruments), Application (Hernia, Dural, Orthopedic, Skin, Dental, Vaginal, Breast augmentation) - Global Forecasts (2022 - 2027)

Report Code: MD 3215 Mar, 2022, by marketsandmarkets.com

[229 Pages Report] The global soft tissue repair market is projected to reach USD 17.2 Billion by 2027, growing at a CAGR of 4.7% during the forecast period. Growth in this market is mainly driven by the growing incidence of sports injuries, increasing aging population and obesity rate, strong focus on R&D leading to the launch of technologically advanced products, etc. But uncomplimentary reimbursement scenario of soft tissue repair products are the key factors restraining the growth of the market. In this report, the market is segmented on the basis of product, end user, application, and region.

Soft Tissue Repair Market

To know about the assumptions considered for the study, Request for Free Sample Report

Impact of Covid-19 on soft tissue repair market

To assess the impact of COVID-19 and provide market forecasts, scenario-based approaches are considered.

Due to the COVID-19 outbreak, we estimate that a major share of the medical device industry, including imaging devices, dental care devices, and surgical products, among other products, which contribute 60– 75% of the overall medical devices market, witnessed a stagnant growth rate/significant reduction in the growth rate in 2020 and the first half of 2021. A new USD 5–7 billion market opportunity (by the second half of 2021) is opening up in the medical device industry, including for critical care medical devices.

Owing to the growing incidence of COVID-19, hospitals became high-risk zones, specifically for patients suffering from chronic conditions. As a result, non-critical procedures such as elective surgeries were either canceled or postponed during the first and second quarters of 2020, which resulted in a significant decline in the total number of elective surgical procedures performed. As a result, the demand for soft tissue repair products witnessed a sharp decline in 2020. The second wave of COVID-19 further deprioritized elective surgical procedures. Governments across the globe have also issued limitations and bans on medical procedures and elective surgeries.

With the current pandemic scenario, surgical procedures have witnessed a decline and are only expected to increase in the third quarter of 2021 in countries such as the US. Some countries in the EU have resumed surgical interventions, which has increased the demand for soft tissue products in the region.

Smith & Nephew reported a decline of ~13.1% in the net sales of its Sports Medicine segment (that offers products for soft tissue repair) in FY 2020 (compared to FY 2019). Similarly, Johnson & Johnson reported a decline of ~13.4% in its revenue growth in the surgery segment in FY 2020.

The following factors are playing a key role in shaping the growth of the global market:

  • The outbreak of COVID-19 increased at an exponential level in the US in the first half of 2020. This led to a decline in regular patient visits to hospitals and clinics and also led to a decline in the number of elective surgeries being conducted per week. However, as of June 10, 2021, the lockdowns have been lifted in the US as well as several countries globally, which is expected to contribute to the slow recovery of the market. Additionally, as soon as hospitals reprioritize elective surgeries, market growth would resume in several countries.
  • Due to the rapid spread of COVID-19, medical supplies experienced a risk of supply shortage due to the temporary lockdown of manufacturing sites in areas affected by COVID-19 or travel restrictions impacting shipments in countries like India. However, owing to the increasing vaccination drives and growing control over the spread of the COVID-19 pandemic, the market is expected to normalize during the forecast period.

Soft Tissue Repair Market Dynamics:

Drivers: Increasing aging population and obesity rate

Age-related physiological changes and metabolic inefficiencies often result in chronic diseases such as cystic fibrosis, hepatitis, cardiovascular disorders, and cancer. The elderly are more susceptible to various soft tissue injuries. For example, according to a register study from the United Kingdom, the prevalence of hernia increased with age from 5% in the age group 25 to 34 years, through 10% in the age group 35 to 44 years, 18% in the age group 45 to 54 years, 24% in the age group 55 to 64 years, 31% in the age group 65 to 74 years, and 45% among men aged 75 years and over. According to an article published in Advances in Orthopedic Surgery journal, more than 40% of the population aged 60 years and above suffers from a rotator cuff tear.

Globally, there were 900 million persons aged 65 years or over in 2020. Since women live longer than men, on average, they comprise the majority of older persons, especially at advanced ages. Over the next three decades, the number of older persons worldwide is projected to more than double, reaching over 2 billion in 2050. All regions will see an increase in the size of the older population between 2020 and 2050. Globally, the share of the population aged 65 years or over is expected to increase from 9.3 per cent in 2020 to around 16.0 percent in 2050.

As per FDA, more than one million hernia repairs are performed each year in the U.S. Approximately 800,000 are to repair inguinal hernias and the rest are for other types of hernias. Similar trends are observed in other developed and developing countries as well. Thus, the increasing aging population, coupled with rising disposable income and greater per capita healthcare expenditure, is expected to drive the demand for soft tissue repair surgeries in the forecast period of 2022 to 2025.

Growing incidence of sports injuries

Globally, there is increasing awareness about the benefits of sports and physical activities on health. This has increased the popularity of sports among the youth. Owing to this, the number of people participating in various sports has also increased significantly over the years. For instance, according to national basketball league of US, In 2020, the number of participants (aged six years and older) in basketball amounted to approximately 24.23 million.

These sports are also becoming popular in Asian countries such as China, Korea, India, and the Eastern Bloc countries. According to the annual High School Athletics Participation Survey conducted by the National Federation of State High School Associations (NFHS), the number of participants in high school sports increased for the 25th consecutive year in 2020–2021.

Research by Sports Medicine Research Institute shows a significant rise of soft tissue injuries in a younger generation involved in athletic activities. Sports and many recreational activities for children can lead to a number of accidents and soft tissue injuries as well as hard tissue injuries such as fractures. With the increasing sports participation across the globe, the number of sports-related soft tissue injuries is estimated to increase, which will drive the soft tissue repair market.

According to the American Academy of Orthopaedic Surgeons (AAOS), an estimated 200,000 anterior cruciate ligament (ACL) injuries are reported annually in the U.S., with around 100,000 ACL reconstructions performed each year. According to papers published by the IEEE Journal of Biomedical and Health Informatics, the number of Americans suffering from ACL injury disease and knee joint osteoarthritis is estimated to cross 60 million by 2025. This significant increase in soft tissue injury is expected to drive the market of soft tissue repair in the next decade.

Strong focus on R&D leading to the launch of technologically advanced products

The biosurgery market is witnessing a significant rise in the launch of new and advanced products, globally. Vendors across the globe are relying on organic growth strategies to efficiently address end-user requirements and demands. As a result, a significant share of their capital investments is being diverted to R&D. This is an important trend in this market as new products with high efficacy and success rates gain rapid adoption among end users. As a result, product launches and innovations in products have become key strategies to gain a competitive edge in this market.

Over the last few decades, a continuous rise in R&D investments has been observed specifically among the established players. This has led to the development of soft tissue repair products for various applications. In FY 2020, Smith & Nephew invested ~USD 492 million in R&D, an increase of 15.3% in comparison to FY 2019. Similarly, Baxter International invested ~USD 521 million in R&D.

Regulatory bodies in several countries have approved various products, such as grafts and adhesion barriers, for use in a number of medical applications. A rising number of products are also getting approved for additional indications, which is increasing the application/use of these products and also helping companies to enter into additional markets through their existing products.

Some of the recent approvals for biosurgery products are mentioned below:

  • In February 2020, Baxter announced FDA 510(k) clearance for its Peri-Strips Dry with Veritas Collagen Matrix product with Secure Grip. The product is a staple line reinforcement agent and is indicated for mitigating bleeding during bariatric surgeries and other surgical procedures.
  • In February 2020, Integra LifeSciences Holdings Corp. launched the AmnioExcel Plus Placental Allograft Membrane for use in soft-tissue repair.
  • In October 2020, Orthofix Medical Inc. (US) announced the launch of the O-GENESIS Graft Delivery System and AlloQuent Structural Allograft Q-Pack, which are ready-to-use cervical and lumbar spacers for allograft procedures.

In September 2019, Medtronic launched several new procedural solutions, including Fibercel Viable Bone Matrix, to reinforce its product portfolio for spine surgeries.

Increasing volume of surgeries and growing prevalence of severe trauma injuries

Over the years, there has been a significant rise in the number of surgical procedures across the globe. According to WHO estimations (2019), approximately 235 million major surgical procedures are undertaken worldwide every year. This is attributed to the growing prevalence of obesity and other lifestyle diseases, rising geriatric population, increasing prevalence of orthopedic conditions, and the increasing incidence of spinal injuries and sports-related injuries.

According to the Heart and Circulatory Disease Statistics 2019 from the British Heart Foundation (UK), there has been a significant increase in the number of cardiac surgical procedures such as angioplasty and aortic valve replacement in the UK over the last decade, and this trend is expected to continue in the coming years.

Soft Tissue Repair Market

To know about the assumptions considered for the study, download the pdf brochure

Soft tissue repair products are finding substantial application in severe trauma injuries, including traumatic brain injuries (TBIs), spinal cord injuries, spine fractures, collapsed lungs, and subarachnoid hemorrhage. According to the Centers for Disease Control and Prevention (CDC), in 2019, TBIs accounted for about 61,000 injury-related deaths in the US, which is about ~166 deaths due to TBIs every day. The growing prevalence of trauma injuries such as TBIs and injuries caused due to falls and accidents is expected to increase the number of trauma surgeries performed across the globe. This is a key indicator of market growth during the forecast period.

Soft tissue repair products such as tissue and grafts, and suture anchors play a key role in cosmetic surgeries and reconstructive plastic surgeries. The American Society of Plastic Surgeons (ASPS) released its annual plastic surgery procedural statistics, reporting that 1.8 million surgical cosmetic procedures and 15.9 million minimally invasive cosmetic procedures were performed in the US in 2020; this represented an increase of 2% and 1% over the procedures conducted in 2017, respectively. In addition, 5.8 million reconstructive procedures were performed in the US during the same period.

Accident and trauma cases and sports injuries are among the major factors increasing the volume of surgeries performed across the globe. According to the WHO global status report (2020), there is a growth in the global number of accidents and trauma cases. About 1.35 million people die each year due to accidents, and about 20 to 50 million sustain non-fatal injuries due to road crashes.

Hands, upper extremities, and legs are the most vulnerable body parts to sports injuries. According to the facts and statistics for sports injuries provided by the National Safety Council (NSC, US), in 2020, the incidence of sports injuries across sports activities such as martial arts, boxing, and skateboarding increased by 3.7% from 2007 to 2020 in the US. The rising incidence of sports injuries is increasing the number of orthopedic and reconstructive surgeries performed across the globe. This is expected to drive the growth of dependent markets, including the markets for Tissue Patch/Mesh.

Restraints: Unfavorable reimbursement scenario

The unfavorable reimbursement scenario in most countries across the globe is a major factor restricting the growth of the soft tissue repair market. According to the Centers for Medicare & Medicaid Services (CMS), there have been a number of changes in payment policies and rates for physicians and non-physician practitioners with regard to services paid under the Medicare Physician Fee Schedule in 2020. CMS has issued a five-year review of work relative value units (RVUs) with orthopedic procedures. The total RVU includes the following three components—the work RVU, which captures the time and effort required by the physician to perform the procedure; the practice expense RVU, which captures the cost in terms of staff labor, equipment, supplies, and rent; and the malpractice RVU, which captures a portion of the malpractice cost.

As a result of the CMS review, the overall procedural reimbursements from Medicare have decreased. In 2019, RVUs for orthopedic surgery decreased by about 1%. Any further decrease in Medicare reimbursements is expected to have a negative impact on the growth of the soft tissue repair market in the coming years.

In addition to this, From 2011 to 2021, the national inflation rate was 16.3%. Unadjusted reimbursement rates for open and laparoscopic inguinal hernia repairs increased by 6.5% and 7.2%, respectively. There was an increase in unadjusted reimbursement for open appendectomies of 5.1% and 6.1% for laparoscopic. Unadjusted reimbursement for open cholecystectomies increased by 4.4%, butdecreasedby 6.8% for laparoscopic. When adjusted to 2021 values, reimbursement for all six operations decreased. Laparoscopic and open cholecystectomies experienced the largest decreases (19.8%, 10.2%).

High price of soft tissue repair products and the rising cost of surgical procedures

The high cost, coupled with the unfavorable reimbursement scenario for these products in several countries, makes them unaffordable for a large section of the target patient population. Currently, the soft tissue market is extremely competitive in terms of pricing, owing to the high competitive intensity among existing players. Most of the products available in this market are priced at a premium. To reduce the growing healthcare costs, governments in several countries across the globe have undertaken efforts to redesign their respective healthcare reimbursement systems. For instance, the US government has planned to reduce Medicare spending by USD 716 billion from 2012 to 2022. This is being achieved by bringing about a 2% cut in the Critical Access Hospitals (CAH) Medicare payments. The reduction in such expenditure has negatively affected the overall quality of healthcare provided to patients. In addition, in 2018, the CMS cut payments by 0.4% (USD 80 million) for home healthcare agencies over the 2017 budget.

Due to the high cost further restricting the adoption of many soft tissue repair products. Also, the these products currently available in the market are made of complicated reconstitutes with a poor shelf life. Hence, there is a growing need for low-priced products that are easy to handle and have a better shelf life.

Opportunitie: Increasing adoption of soft tissue repair products in emerging markets

The penetration of soft tissue repair products is increasing across emerging countries based in the Asia Pacific, Latin America, and the Middle East and Africa. In the coming years, countries such as China, India, and Brazil are expected to offer significant growth opportunities for players operating in the soft tissue repair market. This is because the markets in these countries are characterized by a large patient base for target indications (such as cardiovascular, orthopedic, general/abdominal, and gynecological disorders), rising health awareness, growing healthcare expenditure, rising medical tourism, and rapidly developing healthcare infrastructure. For instance, cardiovascular diseases are currently the leading cause of mortality in India. In 2020, about 25% of deaths in India were caused due to heart diseases and stroke, responsible for about 80% of the healthcare burden.

Over the last few decades, countries such as India and Malaysia have emerged as hubs for medical tourism. This is because the cost of medical procedures across these emerging countries is significantly less in comparison to developed countries such as the US, Germany, France, and the UK. Also, the presence of skilled surgeons and the availability of well-equipped surgical care facilities across private hospital chains are driving the number of medical tourists traveling to these countries for treatment.

Soft Tissue Repair Market

Government agencies in several Asia Pacific countries are undertaking initiatives to support their respective healthcare systems. Owing to the healthcare reforms in China and the 13th Five-year plan, about 1.35 billion people participated in the basic medical insurance program, and about 95% of Chinese citizens were insured. Similarly, according to 2020 statistics from the World Bank, healthcare spending in Latin America increased to about 7.93% of total GDP in 2019 from about 6.53% of total GDP in 2002. Such developments have further opened up the soft tissue repair market across emerging countries. As a result, a number of players operating in the global market are focusing on capturing a greater share in emerging markets. With the growing market potential in the APAC region, many leading players in the biosurgery market are making significant investments in emerging APAC countries.

Similarly, countries such as Saudi Arabia and the UAE are focusing on building healthcare facilities for primary care, secondary hospital segment, and preventive and diagnostic care for their population. Authorities in the UAE are also undertaking initiatives to convert the country into a medical tourism hub. This is expected to create various growth opportunities for stakeholders operating in the healthcare market in the Middle East.

Rising use of grouping materials for enhancing product efficacy

The performance of soft tissue repair products significantly depends on the type of biologics and materials used in their manufacturing. The use of new materials and agents is helping vendors to overcome the limitations (related to biocompatibility, infection, and inflammation) with conventional products and to launch products that outperform popular products in terms of biological response and effectiveness.

Several vendors are using the combination approach, which makes use of the best traits of two different materials in an attempt to provide improved care. For instance, many vendors are offering polyester- and polytetrafluoroethylene-based combined meshes for use in hernia repair procedures. With the increasing success rate of combination materials and the benefits offered by the unique combination of materials, several companies are focusing on the development and launch of these products. For instance, the Fibrin-PTH (KUR-113) product candidate is about to enter Phase 2a clinical trials in the US. The product is a drug-biologic combination for use in spinal interbody fusion.

Such novel approaches with material use have helped vendors to improve product performance and reduce the duration of patient stay across healthcare settings (after surgical procedures). As a result, soft tissue products made using combined biocompatible materials are gaining rapid adoption, thereby providing lucrative growth opportunities to market players.

Challenges: Stringent regulatory framework

The development of new soft tissue repair products requires significant investments, and new products generally take more than 7–8 years for gaining marketing approval. For instance, in the US, the FDA has made it mandatory for soft tissue repair product manufacturers to obtain Premarket Approval (PMA) for their products before they are introduced in the market. For this, the product has to demonstrate proper clinical trial data, which has to be submitted along with the application for PMA. The cost and time required for a product to enter the clinical trial step and then clear the clinical trials are very high, with minimum chances of the product gaining approval. Also, the possibility of obtaining clinically significant data showing clinical trial clearance has been low for soft tissue repair products such as adhesion barriers, semi-synthetic sealants, and hemostatic agents. Soft tissue repair products are considered Class III products, owing to which these products require strict adherence to regulatory guidelines. Hence, despite huge investments in R&D, the risk of failure is very high in the case of soft tissue repair products. This is a major factor limiting the development of novel soft tissue repair products in the market.

In the US, For specific applications such as in ophthalmology, urology, and neurology, approval requires preclinical and clinical data demonstrating safety and efficacy during surgical use. Thus, stringent regulations, requirement of significant investments for clinical studies, and uncertainty of approval during studies make the development and commercialization of soft tissue products a challenging task for vendors.

Requirement of skilled personnel for the effective use of soft tissue repair products

Conventional products used in wound closure, such as sutures and staples, are increasingly being replaced by advanced biosurgery products. Though these products offer improved outcomes, they need skilled surgeons and physicians for their effective utilization. As the use of soft tissue repair products has different effects and contradictions, the application of these products is very complex. For instance, the improper application of these products can lead to complications such as anastomotic leaks in patients.

Currently, the lack of skilled surgeons, both in developed and developing economies, is one of the major factors limiting the adoption of these products. For instance, the Association of American Medical Colleges (AAMC) projects a shortage of about 122,000 physicians by 2032 in the US. Of these, a shortage of 67,000 specialists and 23,000 surgeons is expected to occur by 2032. Similarly, the Health Resource and Services Administration (HRSA) projects a shortage of 5,080 orthopedic surgeons in the US by 2025.

The technology landscape and application areas of soft tissue repair products are changing rapidly, owing to technological advancements in this field. This necessitates physicians and other healthcare providers to acquire the necessary skills to apply advanced soft tissue repair products such as allograft, Xenograft, and Synthetic Mesh. Therefore, surgeons and physicians in hospitals and clinics are reluctant to use advanced surgical products for wound closure.

Market Overview- Executive summery

In this report, the soft tissue repair market is segmented on the basis of product, application, end user, and region.

“Tissue Patched/Mashes accounted for the largest share in the soft tissue repair market by product type”

Based on product, market is segmented into tissue patch/mash and laproscopic intrument injectors. In 2021, Tissue Patch/Mesh accounted for the larger share of 91.9% of the market. This product segment is projected to reach USD 15,892.3 million by 2027 from 12,547.2 million in 2022, at a CAGR of 4.8% during the forecast period. The large share of this segment is attributed to the increasing use of synthetic Mesh across different types of orthopedic surgeries as they reduce surgical time.

“Hernia Repair accounted for the largest share in the soft tissue repair market by Application”

Based on application type, the market is segmented into Hernia Repair, Dural Repair, Vaginal Sling Procedures, Skin Repair, Orthopedic repair, Dental repair, Breast Reconstruction Repair, and other applications. In 2021, the hernia repair is estimated to account for the largest share of 26.5% of the market, by application. The increasing incidence of hernia cases, sports injuries and the growing prevalence of lifestyle disorders, such as arthritis, osteoporosis, and obesity (leading to orthopedic problems), are some of the major factors responsible for the growth in the number of soft tissue repair surgeries performed globally.

“Hospital segment accounted for the largest share in the soft tissue repair market by End User”

Based on end users, the market is segmented into hospitals, clinics, and other end users (ambulatory surgery centers, emergency care centers, burn care centers, and research institutes). The hospitals segment accounted for the largest share of 93.3% of the market in 2021. This is primarily attributed to the increasing number of surgeries taking place across the globe due to the rising geriatric population and the incidence of various diseases. Moreover, the increasing need to control blood loss and achieve efficient hemostasis and wound closure in trauma cases, injuries, or surgical procedures is leading to the increasing adoption of soft tissue repair products by surgeons.

“North America segment accounted for the largest share in the soft tissue repair market by Region”

On the basis of region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America accounted for the largest share of 43.5% of the market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of the North American market is attributed to the presence of an advanced healthcare system in the region, high and growing number of surgical procedures, higher adoption of advanced products, and the presence of several leading market players in the US.

Geographic Snapshot: soft tissue repair Market

Soft Tissue Repair Market by Region

Key Market Players

Prominent players in the soft tissue repair market include ) Becton, Dickinson and Company (US), Smith & Nephew Plc. (UK), Stryker Corporation (US), Arthrex, Inc. (US), Johnson & Johnson (US), Medtronic Plc. (IE), LifeNet Health, Inc.(US), Zimmer Biomet (US), CryoLife, Inc. (US), Organogenesis Inc. (US), Baxter International, Inc. (US), ACell Inc. (US), Tissue Regenix Group Plc (UK) and Aroa Biosurgery Ltd. (NZ). These players have adopted various growth strategies such as acquisition, product launches, and expansion to increase their presence and reach in the soft tissue repair market.

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

:

Report Metric

Details

Market Size Available for Years

2020–2027

Base Year Considered

2021

Forecast Period

2022–2027

Forecast Unit

Value (USD Billion)

Segments Covered

By Product, Application, End User and Region

Countries Covered

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of APAC
  • Latin America
  • Middle East and Africa

Companies Covered

Smith & Nephew Plc. (UK), Arthrex, Inc. (US), Stryker Corporation (US), Johnson & Johnson (US), Medtronic Plc. (IE), LifeNet Health, Inc. (US), Becton, Dickinson and Company (US), Integra LifeSciences Corporation (US), CryoLife, Inc. (US), Organogenesis Inc. (US), Zimmer Biomet (US), Baxter International, Inc. (US), ACell Inc. (US), Tissue Regenix Group Plc (UK) and Aroa Biosurgery Ltd. (NZ).

The research report categorizes soft tissue repair market into the following segments and sub-segments:

by Product

  • Tissue Patch/Mesh
    • Synthetic Mesh
    • Biological Mesh
      • Allograft
      • Xenograft
    • Fixation Products
      • Suture Anchors
      • Interference Screws
      • Other Fixation Devices
    • Laparoscopic Instruments

By Application

  • Hernia Repair
  • Dural Repair
  • Vaginal Sling Procedures
  • Skin Repair
  • Orthopedic
  • Dental
  • Breast Reconstruction Repair
  • Other applications

By End user

  • Hospitals
  • Clinics
  • Other end users

By Region

  • North America
    • Us
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of europe
  • Asia pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Latin america
  • Middle east & africa

Recent Developments:

  • In January 2021, Smith & Nephew acquires the Extremity Orthopaedics business of Integra LifeSciences Holdings Corporation.
  • In December 2021, BD acquired Tissuemed, Ltd. (UK), This acquisition complements BD's core portfolio by adding an broadly applicable surgical sealant to a suite of BD biosurgery products already relied upon in the operating room.
  • In January 2021, Relign was acquired by Zimmer Biomet to help fill an important gap in their sports medicine business.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 29)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 MARKETS COVERED – BY REGION
           1.3.3 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
          TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
    1.5 STAKEHOLDERS
    1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 34)
    2.1 RESEARCH APPROACH
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Primary sources
                    2.1.2.2 Key data from primary sources
                    2.1.2.3 Breakdown of primaries
                                FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
                                FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION
          FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2020)
          FIGURE 5 SUPPLY-SIDE ANALYSIS: SOFT TISSUE REPAIR MARKET
          FIGURE 6 TOP-DOWN APPROACH
          FIGURE 7 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MARKET (2022–2027)
    2.3 GROWTH FORECAST
          FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF THE SOFT TISSUE REPAIR MARKET (2021)
    2.4 MARKET BREAKDOWN & DATA TRIANGULATION
          FIGURE 9 DATA TRIANGULATION METHODOLOGY
    2.5 KEY INDUSTRY INSIGHTS
    2.6 LIMITATIONS
           2.6.1 METHODOLOGY-RELATED LIMITATIONS
    2.7 RISK ASSESSMENT
    2.8 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. - 47)
    FIGURE 10 SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
    FIGURE 11 SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    FIGURE 12 SOFT TISSUE REPAIR MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE SOFT TISSUE REPAIR MARKET

4 PREMIUM INSIGHTS (Page No. - 50)
    4.1 SOFT TISSUE REPAIR SYSTEM MARKET OVERVIEW
          FIGURE 14 INCREASING HERNIA CASES AND TRAUMA INJURIES AND GROWING R&D DRIVE THE MARKET
    4.2 REGIONAL MIX: SOFT TISSUE REPAIR MARKET
          FIGURE 15 APAC TO REGISTER THE HIGHEST CAGR OF DURING THE FORECAST PERIOD
    4.3 ASIA PACIFIC: MARKET, BY PRODUCT AND COUNTRY (2021)
          FIGURE 16 TISSUE PATCHES/MESHES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021
    4.4 GEOGRAPHIC GROWTH OPPORTUNITIES
          FIGURE 17 CHINA TO REGISTER THE HIGHEST REVENUE GROWTH DURING THE FORECAST PERIOD
    4.5 DEVELOPED VS. DEVELOPING MARKETS
          FIGURE 18 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 53)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS: IMPACT ANALYSIS
           5.2.1 DRIVERS
                    5.2.1.1 Increasing aging population and obesity rate
                    5.2.1.2 Growing incidence of sports injuries
                    5.2.1.3 Strong focus on R&D
                    5.2.1.4 Increasing volume of surgeries and growing prevalence of severe trauma injuries
                                TABLE 2 UK: INCREASE IN THE NUMBER OF CARDIAC SURGICAL PROCEDURES PERFORMED
           5.2.2 RESTRAINTS
                    5.2.2.1 Unfavorable reimbursement scenario
                    5.2.2.2 High product and procedure costs
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growing adoption of advanced soft tissue repair products in emerging markets
                                TABLE 3 COST OF SURGICAL PROCEDURES: US VS. INDIA (USD)
                    5.2.3.2 Growing use of combination materials for enhancing product efficacy
           5.2.4 CHALLENGES
                    5.2.4.1 Stringent regulatory framework
                    5.2.4.2 Need for skilled personnel
    5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON ECONOMIC SCENARIO IN SOFT TISSUE REPAIR MARKET
    5.4 ECOSYSTEM ANALYSIS
          FIGURE 19 SOFT TISSUE REPAIR MARKET: ECOSYSTEM ANALYSIS
    5.5 PRICING ANALYSIS
          TABLE 4 AVERAGE SELLING PRICE FOR SOFT TISSUE REPAIR PRODUCTS
    5.6 SUPPLY CHAIN ANALYSIS
          FIGURE 20 SUPPLY CHAIN ANALYSIS (2021)
    5.7 PATENT ANALYSIS
           5.7.1 PATENT PUBLICATION TRENDS FOR SOFT TISSUE REPAIR MARKET
                    FIGURE 21 GLOBAL PATENT PUBLICATION TRENDS IN SOFT TISSUE REPAIR, 2016–2021
           5.7.2 TOP APPLICANTS (COMPANIES) OF SOFT TISSUE REPAIR PATENTS
                    FIGURE 22 TOP COMPANIES THAT APPLIED FOR SOFT TISSUE REPAIR PRODUCT PATENTS, 2016–2021
           5.7.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE MARKET
                    FIGURE 23 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR SOFT TISSUE REPAIR PATENTS, 2016–2021
    5.8 VALUE CHAIN ANALYSIS
          FIGURE 24 SOFT TISSUE REPAIR MARKET: VALUE CHAIN ANALYSIS (2021)
    5.9 TECHNOLOGY ANALYSIS
    5.10 KEY CONFERENCES & EVENTS IN 2022–2023
    5.11 REGULATORY LANDSCAPE
           TABLE 5 REGULATORY STANDARDS/APPROVALS REQUIRED FOR SOFT TISSUE REPAIR PRODUCTS, BY COUNTRY/REGION
    5.12 PORTER’S FIVE FORCES ANALYSIS
           TABLE 6 SOFT TISSUE REPAIR MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.12.1 THREAT FROM NEW ENTRANTS
           5.12.2 COMPETITIVE RIVALRY
           5.12.3 BARGAINING POWER OF BUYERS
           5.12.4 BARGAINING POWER OF SUPPLIERS
           5.12.5 THREAT FROM SUBSTITUTES
    5.13 KEY STAKEHOLDERS & BUYING CRITERIA
           5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 25 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 APPLICATIONS
                     TABLE 7 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 APPLICATIONS (%)
           5.13.2 BUYING CRITERIA
                     FIGURE 26 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
                     TABLE 8 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS

6 SOFT TISSUE REPAIR MARKET, BY PRODUCT (Page No. - 73)
    6.1 INTRODUCTION
          TABLE 9 MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
    6.2 TISSUE PATCHES/MESHES
          TABLE 10 MARKET FOR TISSUE PATCHES/MESHES, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 11 MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
           6.2.1 SYNTHETIC MESHES
                    6.2.1.1 Growing popularity is attributed to the availability of raw materials, lack of infectious disease transmission, cost-effectiveness
                                TABLE 12 MARKET FOR SYNTHETIC MESHES, BY COUNTRY, 2020–2027 (USD MILLION)
           6.2.2 BIOLOGICAL MESHES
                    TABLE 13 MARKET FOR BIOLOGICAL MESHES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 14 MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
                    6.2.2.1 Allografts
                               6.2.2.1.1 Biocompatibility and superior aesthetic results drive the use of allografts
                                              TABLE 15 MARKET FOR ALLOGRAFTS, BY COUNTRY, 2020–2027 (USD MILLION)
                    6.2.2.2 Xenografts
                               6.2.2.2.1 Xenografts are more viable than allografts due to availability and size ranges
                                              TABLE 16 SOFT TISSUE REPAIR MARKET FOR XENOGRAFTS, BY COUNTRY, 2020–2027 (USD MILLION)
           6.2.3 FIXATION PRODUCTS
                    TABLE 17 MARKET FOR FIXATION PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 18 MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
                    6.2.3.1 Suture anchors
                               6.2.3.1.1 Growing injury incidence and need for surgery drive demand for suture anchors
                                              TABLE 19 SOFT TISSUE REPAIR MARKET FOR SUTURE ANCHORS, BY COUNTRY, 2020–2027 (USD MILLION)
                    6.2.3.2 Interference screws
                               6.2.3.2.1 Availability of advanced biodegradable screws and development of biocomposites drives the market growth
                                              TABLE 20 MARKET FOR INTERFERENCE SCREWS, BY COUNTRY, 2020–2027 (USD MILLION)
                    6.2.3.3 Other fixation products
                                TABLE 21 MARKET FOR OTHER FIXATION PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)
    6.3 LAPAROSCOPIC INSTRUMENTS
           6.3.1 QUICK RECOVERY, LOW PAIN & INFECTION RATES DRIVE DEMAND FOR LAPAROSCOPIC SURGERY AND ASSOCIATED INSTRUMENTS
                    TABLE 22 MARKET FOR LAPAROSCOPIC INSTRUMENTS, BY COUNTRY, 2020–2027 (USD MILLION)

7 SOFT TISSUE REPAIR MARKET, BY APPLICATION (Page No. - 86)
    7.1 INTRODUCTION
          TABLE 23 MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
    7.2 HERNIA REPAIR
           7.2.1 HERNIA REPAIR ACCOUNTS FOR THE LARGEST SHARE OF THE MARKET
                    TABLE 24 MARKET FOR HERNIA REPAIR, BY COUNTRY, 2020–2027 (USD MILLION)
    7.3 SKIN REPAIR
           7.3.1 INCREASING CASES OF CHRONIC WOUNDS, DIABETIC ULCERS, AND BURNS CONTRIBUTE TO GROWTH OF SKIN REPAIR MARKET
                    TABLE 25 MARKET FOR SKIN REPAIR, BY COUNTRY, 2020–2027 (USD MILLION)
    7.4 ORTHOPEDIC REPAIR
           7.4.1 INCREASING NUMBER OF SPORTS INJURIES DRIVES ORTHOPEDIC REPAIR MARKET
                    TABLE 26 MARKET FOR ORTHOPEDIC REPAIR, BY COUNTRY, 2020–2027 (USD MILLION)
    7.5 DENTAL REPAIR
           7.5.1 RISING DEMAND FOR PREVENTIVE AND COSMETIC DENTAL PROCEDURES DRIVES THE DENTAL REPAIR MARKET
                    TABLE 27 MARKET FOR DENTAL REPAIR, BY COUNTRY, 2020–2027 (USD MILLION)
    7.6 BREAST RECONSTRUCTION
           7.6.1 RISING BREAST CANCER PREVALENCE SUPPORTS MARKET GROWTH
                    TABLE 28 MARKET FOR BREAST RECONSTRUCTION, BY COUNTRY, 2020–2027 (USD MILLION)
    7.7 DURAL REPAIR
           7.7.1 RISING PREVALENCE OF NEUROVASCULAR DISORDERS AND AWARENESS DRIVES THE DURAL MARKET
                    TABLE 29 MARKET FOR DURAL REPAIR, BY COUNTRY, 2020–2027 (USD MILLION)
    7.8 VAGINAL SLING PROCEDURES
           7.8.1 DEMAND FOR VAGINAL SLING PROCEDURES BOLSTERED BY GROWING CASES OF STRESS-INDUCED URINARY INCONTINENCE (SUI) IN WOMEN
                    TABLE 30 MARKET FOR VAGINAL SLING PROCEDURES, BY COUNTRY, 2020–2027 (USD MILLION)
    7.9 OTHER APPLICATIONS
          TABLE 31 MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)

8 SOFT TISSUE REPAIR MARKET, BY END USER (Page No. - 96)
    8.1 INTRODUCTION
          TABLE 32 MARKET, BY END USER, 2020–2027 (USD MILLION)
    8.2 HOSPITALS
           8.2.1 HOSPITALS ARE THE LARGEST END USERS OF SOFT TISSUE REPAIR PRODUCTS
                    TABLE 33 MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)
    8.3 CLINICS
           8.3.1 QUICKER CONSULTATION SERVICES AND MINIMAL PATIENT STAYS ARE ADVANTAGES OFFERED BY CLINICS OVER HOSPITALS
                    TABLE 34 SOFT TISSUE REPAIR MARKET FOR CLINICS, BY COUNTRY, 2020–2027(USD MILLION)
    8.4 OTHER END USERS
          TABLE 35 MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)

9 SOFT TISSUE REPAIR MARKET, BY REGION (Page No. - 101)
    9.1 INTRODUCTION
          FIGURE 27 INDIA AND CHINA TO REGISTER HIGHEST GROWTH RATES IN THE MARKET
          TABLE 36 SOFT TISSUE REPAIR INDUSTRY, BY REGION, 2020–2027 (USD MILLION)
    9.2 NORTH AMERICA
          FIGURE 28 NORTH AMERICA: SOFT TISSUE REPAIR MARKET SNAPSHOT
          TABLE 37 NORTH AMERICA: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 38 NORTH AMERICA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
          TABLE 39 NORTH AMERICA: MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 40 NORTH AMERICA: MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 41 NORTH AMERICA: MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 42 NORTH AMERICA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
          TABLE 43 NORTH AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.2.1 US
                    9.2.1.1 Presence of prominent market players and high per capita income supports market growth in the US
                                TABLE 44 US: MACROECONOMIC INDICATORS
                                TABLE 45 US: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 46 US: MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 47 US: MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 48 US: MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 49 US: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 50 US: MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.2.2 CANADA
                    9.2.2.1 Rising healthcare expenditure and favorable public and private funding supports soft tissue repair market growth
                                TABLE 51 CANADA: MACROECONOMIC INDICATORS
                                TABLE 52 CANADA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 53 CANADA: MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 54 CANADA: MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 55 CANADA: MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 56 CANADA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 57 CANADA: MARKET, BY END USER, 2020–2027 (USD MILLION)
    9.3 EUROPE
          FIGURE 29 EUROPE: SOFT TISSUE REPAIR MARKET SNAPSHOT
          TABLE 58 EUROPE: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 59 EUROPE: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
          TABLE 60 EUROPE: MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 61 EUROPE: MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 62 EUROPE: MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 63 EUROPE: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
          TABLE 64 EUROPE: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.3.1 GERMANY
                    9.3.1.1 Germany holds the largest share of the European market
                                TABLE 65 GERMANY: MACROECONOMIC INDICATORS
                                TABLE 66 GERMANY: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 67 GERMANY: MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 68 GERMANY: MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 69 GERMANY: MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 70 GERMANY: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 71 GERMANY: MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.3.2 FRANCE
                    9.3.2.1 Presence of a well-established healthcare system and growing geriatric population to boost the market growth
                                TABLE 72 FRANCE: MACROECONOMIC INDICATORS
                                TABLE 73 FRANCE: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 74 FRANCE: MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 75 FRANCE: MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 76 FRANCE: MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 77 FRANCE: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 78 FRANCE: MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.3.3 UK
                    9.3.3.1 Growing volume of hernia repair surgeries and cardiovascular surgeries in the UK stimulating market growth
                                TABLE 79 UK: MACROECONOMIC INDICATORS
                                TABLE 80 UK: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 81 UK: MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 82 UK: MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 83 UK: MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 84 UK: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 85 UK: MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.3.4 ITALY
                    9.3.4.1 Increasing volume of surgeries to drive the demand for soft tissue repair products in the country
                                TABLE 86 ITALY: MACROECONOMIC INDICATORS
                                TABLE 87 ITALY: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 88 ITALY: MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 89 ITALY: MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 90 ITALY: MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 91 ITALY: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 92 ITALY: MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.3.5 SPAIN
                    9.3.5.1 Growing healthcare budget and rising efforts for boosting the local manufacturing of medical products to drive market growth
                                TABLE 93 SPAIN: MACROECONOMIC INDICATORS
                                TABLE 94 SPAIN: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 95 SPAIN: MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 96 SPAIN: MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 97 SPAIN: MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 98 SPAIN: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 99 SPAIN: MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.3.6 REST OF EUROPE
                    TABLE 100 ROE: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                    TABLE 101 ROE: MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 102 ROE: MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 103 ROE: MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 104 ROE: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                    TABLE 105 ROE: MARKET, BY END USER, 2020–2027 (USD MILLION)
    9.4 ASIA PACIFIC
          FIGURE 30 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET SNAPSHOT
          TABLE 106 APAC: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 107 APAC: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
          TABLE 108 APAC: MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 109 APAC: MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 110 APAC: MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 111 APAC: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
          TABLE 112 APAC: MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.4.1 JAPAN
                    9.4.1.1 Strong healthcare system and rising geriatric population to support market growth in Japan
                    TABLE 113 JAPAN: MACROECONOMIC INDICATORS
                    TABLE 114 JAPAN: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                    TABLE 115 JAPAN: MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 116 JAPAN: MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 117 JAPAN: MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 118 JAPAN: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                    TABLE 119 JAPAN: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.4.2 CHINA
                    9.4.2.1 Growing number of hospitals and healthcare policy reforms stimulating market growth
                    TABLE 120 CHINA: MACROECONOMIC INDICATORS
                    TABLE 121 CHINA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                    TABLE 122 CHINA: MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 123 CHINA: MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 124 CHINA: MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 125 CHINA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                    TABLE 126 CHINA: MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.4.3 INDIA
                    9.4.3.1 Rising healthcare awareness and favorable government support to stimulate market growth in India
                    TABLE 127 INDIA: MACROECONOMIC INDICATORS
                    TABLE 128 INDIA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                    TABLE 129 INDIA: MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 130 INDIA: MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 131 INDIA: MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 132 INDIA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                    TABLE 133 INDIA: MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.4.4 REST OF ASIA PACIFIC
                    TABLE 134 ROAPAC: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                    TABLE 135 ROAPAC: MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 136 ROAPAC: MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 137 ROAPAC: MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 138 ROAPAC: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                    TABLE 139 ROAPAC: MARKET, BY END USER, 2020–2027 (USD MILLION)
    9.5 LATIN AMERICA
           9.5.1 LOW-COST SURGERIES ATTRACT MEDICAL TOURISTS TO LATIN AMERICA
                    TABLE 140 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                    TABLE 141 LATIN AMERICA: MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 142 LATIN AMERICA: MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 143 LATIN AMERICA: MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 144 LATIN AMERICA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                    TABLE 145 LATIN AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
    9.6 MIDDLE EAST & AFRICA
           9.6.1 MEA IS THE SMALLEST REGIONAL MARKET FOR BIOSURGERY PRODUCTS
                    TABLE 146 MEA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                    TABLE 147 MEA: MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 148 MEA: MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 149 MEA: MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 150 MEA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                    TABLE 151 MEA: MARKET, BY END USER, 2020–2027 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. - 153)
     10.1 OVERVIEW
     10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
     10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
             FIGURE 31 REVENUE ANALYSIS OF THE TOP PLAYERS IN THE SOFT TISSUE REPAIR MARKET
     10.4 MARKET SHARE ANALYSIS
             FIGURE 32 SOFT TISSUE REPAIR MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
     10.5 COMPANY EVALUATION QUADRANT
             10.5.1 STARS
             10.5.2 PERVASIVE PLAYERS
             10.5.3 EMERGING LEADERS
             10.5.4 PARTICIPANTS
                        FIGURE 33 SOFT TISSUE REPAIR MARKET: COMPANY EVALUATION MATRIX, 2021
     10.6 COMPETITIVE LEADERSHIP MAPPING FOR SMES & START-UPS
             10.6.1 PROGRESSIVE COMPANIES
             10.6.2 DYNAMIC COMPANIES
             10.6.3 STARTING BLOCKS
             10.6.4 RESPONSIVE COMPANIES
                        FIGURE 34 SOFT TISSUE REPAIR MARKET: COMPANY EVALUATION MATRIX FOR SMES & START-UP
     10.7 COMPETITIVE BENCHMARKING
             10.7.1 OVERALL COMPANY FOOTPRINT
                        TABLE 152 OVERALL COMPANY FOOTPRINT (25 COMPANIES)
                        TABLE 153 COMPANY FOOTPRINT: BY PRODUCT (25 COMPANIES)
                        TABLE 154 COMPANY FOOTPRINT: BY APPLICATION (25 COMPANIES)
                        TABLE 155 COMPANY FOOTPRINT: BY REGION (25 COMPANIES)
     10.8 COMPETITIVE SCENARIO
             10.8.1 DEALS
                        TABLE 156 DEALS
             10.8.2 OTHER DEVELOPMENTS
                        TABLE 157 OTHER DEVELOPMENTS

11 COMPANY PROFILES (Page No. - 167)
(Business Overview, Products Offered, Recent Developments, and MnM View)*
     11.1 KEY PLAYERS
             11.1.1 ARTHREX INC.
                        TABLE 158 ARTHREX INC.: BUSINESS OVERVIEW
             11.1.2 SMITH & NEPHEW PLC
                        TABLE 159 SMITH & NEPHEW PLC: BUSINESS OVERVIEW
                        FIGURE 35 SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2020)
             11.1.3 JOHNSON & JOHNSON
                        TABLE 160 JOHNSON & JOHNSON: BUSINESS OVERVIEW
                        FIGURE 36 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2020)
             11.1.4 BECTON, DICKINSON & COMPANY
                        TABLE 161 BECTON, DICKINSON & COMPANY: BUSINESS OVERVIEW
                        FIGURE 37 BECTON, DICKINSON & COMPANY: COMPANY SNAPSHOT (2020)
             11.1.5 STRYKER CORPORATION
                        TABLE 162 STRYKER CORPORATION: BUSINESS OVERVIEW
                        FIGURE 38 STRYKER CORPORATION: COMPANY SNAPSHOT (2020)
             11.1.6 MEDTRONIC PLC.
                        TABLE 163 MEDTRONIC PLC.: BUSINESS OVERVIEW
                        FIGURE 39 MEDTRONIC PLC.: COMPANY SNAPSHOT (2020)
             11.1.7 ZIMMER BIOMET
                        TABLE 164 ZIMMER BIOMET: BUSINESS OVERVIEW
                        FIGURE 40 ZIMMER BIOMET: COMPANY SNAPSHOT (2020)
             11.1.8 INTEGRA LIFESCIENCES HOLDINGS CORPORATION
                        TABLE 165 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: BUSINESS OVERVIEW
                        FIGURE 41 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT (2020)
             11.1.9 CRYOLIFE INC.
                        TABLE 166 CRYOLIFE INC.: BUSINESS OVERVIEW
                        FIGURE 42 CRYOLIFE INC.: COMPANY SNAPSHOT (2020)
             11.1.10 ORGANOGENESIS INC.
                        TABLE 167 ORGANOGENESIS INC.: BUSINESS OVERVIEW
                        FIGURE 43 ORGANOGENESIS INC.: COMPANY SNAPSHOT (2020)
     11.2 OTHER PLAYERS
             11.2.1 LIFENET HEALTH INC.
                        TABLE 168 LIFENET HEALTH INC.: BUSINESS OVERVIEW
             11.2.2 BAXTER INTERNATIONAL, INC.
                        TABLE 169 BAXTER INTERNATIONAL, INC.: BUSINESS OVERVIEW
                        FIGURE 44 BAXTER INTERNATIONAL: COMPANY SNAPSHOT (2020)
             11.2.3 TISSUE REGENIX GROUP PLC
                        TABLE 170 TISSUE REGENIX GROUP PLC: BUSINESS OVERVIEW
                        FIGURE 45 TISSUE REGENIX GROUP PLC: COMPANY SNAPSHOT (2020)
             11.2.4 CONMED CORPORATION
                        TABLE 171 CONMED CORPORATION: BUSINESS OVERVIEW
                        FIGURE 46 CONMED CORPORATION: COMPANY SNAPSHOT (2020)
             11.2.5 MERIL LIFE SCIENCES PVT. LTD.
                        TABLE 172 MERIL LIFE SCIENCES PVT. LTD.: BUSINESS OVERVIEW
             11.2.6 RTI SURGICAL
                        TABLE 173 RTI SURGICAL: BUSINESS OVERVIEW
             11.2.7 SAMYANG HOLDINGS CORPORATION
                        TABLE 174 SAMYANG HOLDINGS CORPORATION: BUSINESS OVERVIEW
             11.2.8 AROA BIOSURGERY LTD.
                        TABLE 175 AROA BIOSURGERY LTD.: BUSINESS OVERVIEW
             11.2.9 ACERA SURGICAL INC.
                        TABLE 176 ACERA SURGICAL INC.: BUSINESS OVERVIEW
             11.2.10 ORTHOCELL LTD.
                        TABLE 177 ORTHOCELL LTD.: BUSINESS OVERVIEW
             11.2.11 ACELL INC.
                        TABLE 178 ACELL INC.: BUSINESS OVERVIEW
             11.2.12 BIOCER ENTWICKLUNGS-GMBH
                        TABLE 179 BIOCER ENTWICKLUNGS-GMBH: BUSINESS OVERVIEW
             11.2.13 ISTO BIOLOGICS
                        TABLE 180 ISTO BIOLOGICS: BUSINESS OVERVIEW
             11.2.14 BETATECH MEDICAL
                        TABLE 181 BETATECH MEDICAL: BUSINESS OVERVIEW
             11.2.15 MIMEDX
                        TABLE 182 MIMEDX: BUSINESS OVERVIEW
                        FIGURE 47 MIMEDX: COMPANY SNAPSHOT (2020)

* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.

12 APPENDIX (Page No. - 222)
     12.1 INDUSTRY INSIGHTS
     12.2 DISCUSSION GUIDE
     12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     12.4 AVAILABLE CUSTOMIZATIONS
     12.5 RELATED REPORTS
     12.6 AUTHOR DETAILS

This study involved four major approaches in estimating the current soft tissue repair market size. Extensive research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the value market. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

This research study involved widespread secondary sources; directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; white papers; annual reports; company house documents; investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the soft tissue repair market. It was also used to obtain important information about key players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the soft tissue repair market. Primary sources from the demand side include personnel from hospitals, hospital staff and C-level executives.

Market Size Estimation

The total size of the soft tissue repair market was arrived at after data triangulation from four different approaches, as mentioned below.

Bottom-up Approach: Revenues of individual companies were gathered from public sources and databases. Shares of the soft tissue businesses of leading players were gathered from secondary sources to the extent available. In certain cases, the share of the business unit was ascertained after a detailed analysis of various parameters, including product portfolio, market positioning, selling price, and geographic reach and strength. Individual shares or revenue estimates were validated through expert interviews.

Country level Analysis: The size of the soft tissue repair market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of soft tissue repair products in the overall soft tissue repair market was obtained from secondary data and validated by primary participants to arrive at the total soft tissue repair market. Primary participants further validated the numbers.

Primary Interviews: As a part of the primary research process, individual respondent insights on the market size and growth were taken during the interview (regional and global, as applicable). All the responses were collated, and a weighted average was taken to derive a probabilistic estimate of the market size and growth rate.

Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:

Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall soft tissue repair market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

Breakdown of Primary Interviews

Soft Tissue Repair Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Soft Tissue Repair Market Size, and Share

Data Triangulation

After arriving at the market size, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed wherever applicable.

Approach to derive the market size and estimate market growth

The market rankings for leading players were ascertained after a detailed assessment of their revenues from the soft tissue repair business using secondary data available through paid and unpaid sources. Owing to data limitations, in certain cases, the revenue share was arrived at after a detailed assessment of the product portfolios of major companies and their respective sales performance. At each point, this data was validated through primary interviews with industry experts.

Objectives of the Study

  • To define, describe, analyze, and forecast the soft tissue repair market by product, application, end user, and region1
  • To provide detailed information about the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
  • To analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the soft tissue repair market in North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To strategically profile key players in the global soft tissue repair market and comprehensively analyze their core competencies2
  • To track and analyze competitive developments such as product launches, expansions, acquisitions, partnerships, and agreements, in the global soft tissue repair market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

Product Analysis

  • Further segmentation of individual product segments by application and end user

Geographic Analysis

  • Further breakdown of the Rest of Asia Pacific soft tissue repair market into South Korea, Australia, New Zealand, and others
  • Further breakdown of the Rest of Europe soft tissue repair market into Belgium, Russia, the Netherlands, Switzerland, and others

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)
Soft Tissue Repair Market Size,  Share & Growth Report
Report Code
MD 3215
Published ON
Mar, 2022
Choose License Type
BUY NOW
GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

SEND ME A FREE SAMPLE
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2022 MarketsandMarkets Research Private Ltd. All rights reserved